Page 256 - 20211214_OHKF_Health_Finance_Research_Report_E (1)
P. 256

APPENDIX P: CALCULATIONS OF PARAMETERS



               Table 4
                 Calculations for parameter values


                       Parameters             Value            Reference            Calculations Involved
                 Starting points
                 Pre-diabetes prevalence as   1.24%      (CHP, 2017, 2018, 2020c)
                 at 2022
                 Already have diagnosis      2.46%       (CHP, 2017, 2018, 2020c)
                 before 2022
                 Diabetic but without        4.86%       (CHP, 2017, 2018, 2020c)
                 diagnosis before 2022
                 Flows parameters
                 Incidence of pre-diabetes   0.99%       (Quan et al., 2017)   Average rate of change in
                 from no diagnosis                                             prevalence of diabetes
                 Base Case-Incidence of new   3.73%      (Okada et al., 2017)
                 DM cases from pre-diabetes
                 cases
                 Scenario 1 and 2-Incidence   2.80%      (Okada et al., 2017)
                 of new DM cases from
                 pre-diabetes cases
                 Regression rate from pre-   2.82%       (Paprott et al., 2018)  Regression of 33.6% over 12 years
                 diabetes to normoglycaemia                                    from the pre-diabetic population
                 Scenario 1 and 2-Remission   7.00%      (Ried‐Larsen et al., 2019)
                 rate from diabetes to pre-
                 diabetes
                 Assumed complication rate    150%       (Song & Hardisty, 2009)  There is no consistent/aggregate
                 multiplier of 20Y+                                            value for multiplier of complication
                                                                               rates. For Macrovascular
                                                                               complications after 20 years, the
                                                                               adjustment factor ranges from 1.06
                                                                               to 1.75. For Microvascular
                                                                               complications, the factor ranges
                                                                               from 1.37 to 1.90. The average
                                                                               adjustment factor is 1.49, or 150%.
                 Complications rates and costs
                 Base Case and Scenario 1
                   Complications rate (usual   6.20%     (Jiao et al., 2018)
                   care)
                   Complications cost per   HKD 106,523.39  (Jiao et al., 2018)  [USD 19,561 * 7.8 HKD/USD *
                   patient (usual care)                                        1/5 years]*[N=8,570]/[2,455
                                                                               Observed complication events]
                   Cost per “healthy” patient,   HKD 5,705.28  (Jiao et al., 2017)  [exp(9.381) * 1.05(50–65)]
                   aged 45–54 (usual care)
                   Cost per “healthy” patient,   HKD 9,293.30  (Jiao et al., 2017)
                   aged 55–64 (usual care)
                   Cost per “healthy” patient,   HKD 15,137.81  (Jiao et al., 2017)
                   aged 65–74 (usual care)
                 Scenario 2
                   Complications rate (RAMP)  3.81%      (Jiao et al., 2018)
                   Complications cost per   HKD 123,363.56  (Jiao et al., 2018)  [USD 12,110 * HKD/USD 7.8 / 5
                   patient (RAMP)                                              years]*[N=8,570]/[1,315 Observed
                                                                               complication events]
                   Cost of RAMP            HKD 244.92    (Jiao et al., 2018)
                   Cost per “healthy” patient,   HKD 5,950.20  (Jiao et al., 2017, 2018)  usual_cost + [USD 157 * HKD/USD
                   aged 45–54 (RAMP)                                           7.8 * 1/5years]
                   Cost per “healthy” patient,   HKD 9,538.22  (Jiao et al., 2017, 2018)
                   aged 55–64 (RAMP)
                   Cost per “healthy” patient,   HKD 15,382.73  (Jiao et al., 2017, 2018)
                   aged 65–74 (RAMP)
                 Cost of intervention for   HKD 3,486.00  (HA, 2021f)
                 diagnosed DM patients



       254
   251   252   253   254   255   256   257   258   259   260   261